Objective: Symptoms of chronic fatigue syndrome (CFS) can be perpetuated by cognitive and behavioral responses to the illness. We aimed to determine the factor structure, reliability, and validity of the 40-item Cognitive and Behavioural Responses Questionnaire (CBRQ) using data gathered from CFS patients. We also propose a short-version CBRQ for greater clinical utility. Methods: The psychometric analysis was performed on data sets drawn from two sources: a clinical service for CFS patients (n = 576) and the PACE randomized controlled trial of CFS treatments (n = 640). An exploratory factor analysis was conducted on the clinical data set and a confirmatory factor analysis was performed on the randomized controlled trial data set. Using these results, a short version of the CBRQ was proposed. Reliability, metric invariance across age and sex, and construct validity were assessed. Results: The exploratory factor analysis (relative χ 2 = 2.52, root mean square error of approximation = 0.051, comparative fit index = 0.964, Taylor-Lewis Index = 0.942) and confirmatory factor analysis (relative χ 2 = 4.029, root mean square error of approximation = 0.069, comparative fit index = 0.901, Taylor-Lewis Index = 0.892) revealed that eight-factor models fitted the data well. Satisfactory Cronbach's α values were obtained for the final subscales (≥0.76). The shortened CBRQ was obtained by removing items that cross-loaded onto other factors and/or were the lowest loading items in each factor. The shortened CBRQ contained 18 items that had high factor loadings, good face validity, and reliability (Cronbach's α = 0.67-0.88). Conclusions: The CBRQs, long and short versions, are reliable and valid scales for measuring cognitive and behavioral responses of patients with CFS. Further research is needed to examine the utility of the CBRQ in other long-term conditions.
INTRODUCTION C
hronic fatigue syndrome (CFS), or myalgic encephalomyelitis (ME), is a disorder that is characterized by severe and debilitating fatigue that is not alleviated by rest, persists for more than 6 months, and has no identified medical cause (1) . CFS patients often have difficulty working and recovery without treatment is uncommon (2, 3) .
Most studies have found that CFS patients do not have significant differences in physiological test results compared with controls (4, 5) . Shortly after its recognition as an illness (6, 7) , clinical researchers postulated a cognitive behavioral model of CFS that hypothesized that CFS symptoms are perpetuated by the patients' cognitive and behavioral responses to the illness (8, 9) . Some of the unhelpful cognitive responses in patients with CFS include excessive focusing on fatigue symptoms (10) and catastrophic interpretations of symptoms, which involve worrying about worst-case potential consequences (11) . These cognitive responses are also associated with behavioral responses in CFS patients, which include reducing or avoiding activities to alleviate fatigue (12, 13) or alternating between high levels of activity when feeling well and resting excessively in response to symptoms. Activity avoidance in some CFS patients can be associated with the belief that activity can exacerbate their symptoms, or it may also result from the embarrassment that they feel when experiencing fatigue symptoms in a social context. The therapies that have been shown to be effective in CFS, such as cognitive behavioral therapy (CBT) (14) , are based on identifying and targeting unhelpful cognitive and behavioral patterns in CFS patients (9) . It follows that accurate measurement of these factors is critical to the assessment of whether treatments are working as expected and to the refinement of treatments, so that they have the maximum possible effect on changing beliefs and behaviors that perpetuate CFS symptoms.
The Cognitive and Behavioural Response Questionnaire (CBRQ) is a 40-item self-rated questionnaire that was designed to measure these cognitive and behavioral responses to patients' illness symptoms. In the development phase, the scale was found to have five cognitive subscales and two behavioral subscales (15) . It was subsequently used to assess symptom beliefs in patients with CFS (16) (17) (18) . The cognitive subscales include fear avoidance, catastrophizing, damaging beliefs, embarrassment avoidance, and symptom focusing. Four subscales assess the interpretation of symptoms, whereas symptom focusing assesses the attentional focus toward symptoms. The behavioral subscales consist of all-or-nothing behavior and avoidance/resting behavior. Table S1 in the Supplemental Digital Content, http://links.lww.com/PSYMED/A423, describes the CBRQ items that make up the subscales. These subscales were based on a previously completed preliminary analysis, which was reported in conference proceedings (15) . The aims of this article were to see whether the seven-factor subscale structure (15) would be confirmed using new data sources or whether a different subscale structure would be more appropriate and to formally assess the validity of the CBRQ items. No formal psychometric analysis of the CBRQ has been published as yet. We also propose a shorter version of the CBRQ, based on the psychometric analysis results of the full questionnaire that retains cognitive and behavioral items, and test the reliability and validity of this short version. Through the development and implementation of this short version of the CBRQ, we hope to reduce participant burden, reduce the risk of having random responses, and also obtain a questionnaire with as strong indicators as possible (by removing problematic items).
METHODS

Participants
CBRQ data were drawn from two sources: a routine clinical service and the pacing, graded activity, and cognitive behavior therapy: a randomized evaluation (PACE) trial ( (14); ISRCTN54285094). The CBRQ is a self-report questionnaire that the participants filled out on paper. Other measurements, such as the 36-item Medical Outcomes Study Short-Form Health Survey (SF36) (19), Work and Social Adjustment Scale (WSAS) (20), Chalder Fatigue Scale (CFQ) (21) , and anxiety and depression measured using the Hospital Anxiety and Depression Scale (HADS) (22) were also collected. For both data sets, only baseline measures were used in these analyses to avoid treatment effects.
Clinical Data Set
Routine deidentified screening data were collected on 728 adult patients (≥18 years) that were assessed at the Chronic Fatigue Research and Treatment Unit in London, United Kingdom, between November 2007 and January 2014. These patients were selected in accordance with the Oxford criteria for diagnosing CFS (7) . All participants were medically assessed by the specialist clinic doctors to exclude alternative diagnoses (23) .
Patients were excluded from analysis if they did not have CBRQ data (n = 64), did not have a diagnosis of CFS (n = 70), had bipolar (affective) disorder (n = 4), had an eating disorder (n = 1), had seizures (n = 2), or had cancer/were receiving chemotherapy (n = 5) (1). Six entries were removed because they were duplicates of patients (original entries used). After inclusion/exclusion criteria were imposed, the sample was reduced to 576 patients.
These data were collected as part of a clinical audit of routinely collected outcomes; an audit and service evaluation project proposal form was submitted and approved by South London and Maudsley's Psychological Medicine Clinical Academic Group Audit Committee and the clinical governance department, part of King's Health Partners.
RCT/PACE Data Set
Data were collected on 641 patients who were recruited into the PACE study (14) between March 18, 2005 , and November 28, 2008. These patients were 18 years or older and were recruited from consecutive new outpatients attending six specialist CFS clinics in the UK National Health Service. The patients fulfilled the Oxford criteria for CFS, and specialist clinic doctors assessed the participants to exclude alternative diagnoses. The PACE study was approved by the West Midlands Multicentre Research Ethics Committee (MREC 02/7/89) and was the largest UK trial to date of CFS treatments. PACE included three therapies and one medical treatment for CFS. The main results of the trial have been reported elsewhere (14) . One of the PACE participants withdrew consent for use of their data, so the final data set was n = 640.
Measures
The CBRQ was used to assess the patients' cognitive and behavioral responses to their symptoms. The development of the questionnaire is discussed elsewhere (Moss-Morris and Chalder, in preparation).
Each CBRQ item is measured on a five-point Likert scale, scored from 0 (strongly disagree) to 4 (strongly agree), where a higher subscale score indicates more unhelpful cognitions and behaviors. Two of the items, FA2 and FA9, are reverse scored. To calculate the totals, items FA2 and FA9 must first be reverse coded, and the items in each of the subscales (Table S1 Supplemental Digital Content, http://links.lww.com/PSYMED/ A423) are added together to create the subscale scores. Box plots for the original subscale structures in each data set are displayed in Figure S1 in the Supplemental Digital Content, http://links.lww.com/PSYMED/A423. The SF36 (19) , WSAS (20) , CFQ (21) , and HADS (22) were also used in the analysis to determine construct validity for the CBRQ. The SF36 health survey is a 36-item self-report survey of patient health, where a low score indicates greater impairment. The WSAS is a five-item selfreport scale that measures impairment in work, home management, social activities, private leisure activities and relationships due to an identified problem. The CFQ is an 11-item self-report scale that measures symptoms of physical and mental fatigue. From this scale, a total score or a bimodal score can be obtained. The HADS is a 14-item self-report instrument for detecting states of depression and anxiety in patients with medical illnesses. For the WSAS, CFQ and HADS high scores indicate greater impairment. These measures were collected in both data sets.
Statistical Analyses
Exploratory and Confirmatory Factor Analyses
The factor structure of the CBRQ was assessed using factor analysis techniques for categorical data. Since no formal psychometric analysis of the CBRQ has been published, we began with an exploratory factor analysis (EFA) to determine possible factor structures. EFA was conducted with the clinical CFS data set and confirmatory factor analysis (CFA) was performed with the RCT data set. That is, the clinical data set was used as a "learning" sample for EFA and the RCT data set was used as the "testing" sample for CFA.
When performing the EFA, six-to eight-factor structures were initially examined as these produced fairly parsimonious models with good model fit and interpretability, and reflected previous results (15) . Eigenvalues for the sample correlation matrix, scree plots and parallel analysis for categorical data (24) (using the package random.polychor.pa in R (25)) were also used to confirm this decision (results presented in Supplemental Digital Content, http:// links.lww.com/PSYMED/A423, Figures S2 and S3 ). Initially all 40 items were included in the EFA. The EFA was used to determine the factor structures, and reliability analyses were performed on these factor structures.
Once the EFA was completed, CFA was performed with the RCT data set to test these factor structures. A CFA using the seven-factor structure that was previously proposed (15) (Table S1 , Supplemental Digital Content, http://links.lww.com/PSYMED/A423) was also performed. The EFA and CFA were performed in Mplus (Version 7.4; (26)) to allow for handling of the categorical Likert-scored data. For the EFA, GEOMIN rotation and the weighted least squares means and variance adjusted estimator (WLSMV) were used as recommended by (27) . For the CFA, WLSMV was also used for estimation. We also employed the maximum likelihood estimator in CFA so that the Akaike information criterion (AIC) and Bayesian information criterion (BIC) values could be obtained in Mplus for fit comparison of nonnested models.
Goodness of Fit
Model fit was assessed and compared using the relative χ 2 value (χ 2 /df, where values close to 2 indicate a good fit) (28), the root mean square error of approximation (RMSEA, where values less than 0.08 are required for an adequate fit) (29) , the comparative fit index (CFI, values > 0.9 indicate a good fit) (30), the Taylor-Lewis Index (TLI, values >0.9 indicate a good fit) (31), as well as the factor loadings and face validity of the factors.
Item Reduction
To obtain the shortened version of the CBRQ, we removed items that had the lowest factor loadings (in each factor) and/or loaded saliently on more than one factor (cross-loading) according to EFA results. EFA was used to determine the factor structure of the shortened scale (again, using the clinical data set) and CFA was used to confirm the proposed shortened scale (using the RCT data set). The final shortened version of the CBRQ was chosen based on the item loadings, goodness-of-fit statistics, reliability indices, and the face validity of the items in the factors (according to CFS experts).
Reliability and Validity
Reliability analyses, based on Cronbach's α if item deleted and item-total correlation (within each factor), were conducted in SPSS (Version 22; SPSS, Inc, Chicago, IL). Metric invariance across age (continuous) and sex, as well as data set source (clinical or RCT data set) was assessed using the multiple indicator multiple cause (MIMIC) structural equation model (32) in Mplus (Version 7.4). Construct validity was assessed by examining the correlations between the CBRQ total score and the SF36 total score, WSAS, CFQ, HAD total, HAD anxiety, and the HAD depression score. The results of the MIMIC analyses and construct validity are only presented for the shortened scale; the results for the full scale are available upon request.
To check for the consistency in the factor structure between the two data sets, we pooled the RCT and clinical CFS data sets into one data set, randomly split them into two data sets, and performed EFA on one sample and CFA on the other.
All data available were used in these complete case analyses-no imputation of missing data was performed. In the clinical data set, 0.7% to 1.7% of the values were missing in the CBRQ items. In the PACE data set, 0.2% to 0.6% of the values were missing in the CBRQ items.
RESULTS
Summary of Data Sets
The demographics of the RCT and clinical CFS data sets were quite similar in terms of the patients' age, sex, and marital status (Table 1) . There were some differences between the patients in terms of work status ( p < .001)-more patients were temporarily unable to work in the RCT data set compared with the clinical data set (14.4% versus 23%), whereas the clinical data set had more patients who were permanently unable to work because of illness (16% versus 3%). There were also more unemployed individuals in the RCT data set (8.7% versus 23.6%). There were also significant differences in ethnicity and highest educational qualifications between the two data sets. The duration of illness was generally longer in the clinical data set compared with the RCT data set (median = 48 versus 31.5 months, p < .001). An inclusion criteria for the PACE study was that patients had a CFQ score of 6 or higher; 473 (82.1%) of 576 patients in the clinical data set met this criteria. The M (SD) CFQ score (bimodal) was 9.3 (2.8) in the clinical data set, and the M (SD) in the RCT data set was 10.3 (1.2); a significant difference was found between these means ( p < .001). PACE patients were also required to have an SF36 score of 60 or less, which was later increased to 65 or less; 348 (60.4%) of 576 patients had SF36 score of 60 or less in the clinical data set and 377 (65.5%) of 576 patients had SF36 score of 65 or less. The M (SD) SF36 value in the clinical data set was 46.9 (26.4); the M (SD) SF36 in the RCT data set was 38 (15.7) ( p < .001). Due to trial entry criteria, the RCT patients had worse fatigue and disability than the clinical CFS patients.
Regarding distribution of scores on the CBRQ subscales (scored using the original factor structure), the scores for the damage and embarrassment avoidance subscales were similar between the two data sets (Table 2) ; the fear avoidance, catastrophizing, symptom focusing, all-or-nothing, and avoidance/resting subscales had significant differences between the two data sets in terms of their distribution. In particular, the median scores for the allor-nothing and avoidance/resting subscales were higher in the RCT data set ( Table 2 ).
EFA and CFA Results
The eigenvalues for the full sample correlation matrix indicated that up to eight factors would be sufficient (see Figure S2 , Supplemental Digital Content, http://links.lww.com/PSYMED/A423). Parallel analysis also indicated that up to eight factors should be considered (see Figure S3 , Supplemental Digital Content, http:// links.lww.com/PSYMED/A423 -this is the point immediately before where the plots of the observed (polychoric correlation Empirical FA line) and simulated eigenvalues cross one another (33)).
EFAs using routine clinical data revealed that the best-fitting model that included all items was the eight-factor model (relative χ 2 = 2.52, RMSEA = 0.051 [90% confidence interval {CI} = 0.048-0.055], CFI = 0.964, TLI = 0.942). The seven-factor model also produced a good model fit (relative χ 2 = 3.10, RMSEA = 0.060 [90% CI = 0.057-0.064], CFI = 0.946, TLI = 0.920).The factor loadings and reliability for the eight-factor model can be found in Table 3 . The factor loadings for the seven-factor model may be found in the Supplemental Digital Content, http://links. lww.com/PSYMED/A423 (Table S2) . Because the fit indices are similar between the seven-and eight-factor models, one could choose the seven-factor model on the grounds of parsimony. However, we argue that the eight-factor model better explained the different subscales of the CBRQ because it separated the avoidance and the resting items into two factors and was more interpretable.
Each factor in the eight-factor model had satisfactory reliability (Cronbach's α > 0.7 (34)) and the item-total correlations (within each factor) were between 0.44 and 0.78 (data not shown). Summary statistics for the eight subscales obtained from the EFA and CFA and the total CBRQ score are given in Supplemental Digital Content, http://links.lww.com/PSYMED/A423 (Table S3) . Box plots for each of the subscales in each data set are given in Figures   S1 and S4 in the Supplemental Digital Content, http://links.lww. com/PSYMED/A423.
Apart from the factor on which the items had their largest loading, the items L3, L4, and L11 loaded also on the fear avoidance subscale; the items EA3 and EA4 loaded on both the embarrassment avoidance subscale and the avoidance subscale; items SF1, SF3, and L10 loaded also on the catastrophizing subscale; items C1 and C2 loaded also on the damage subscale; items C4 and C6 loaded also on the symptom focusing subscale. CFA using the RCT data set demonstrated that the seven-factor model (using the original subscale structure) produced the best Similar results were obtained when the two data sets were pooled and randomly split into two data sets with one data set used for the EFA and the other used for CFA (results available upon request).
Shortened Version of CBRQ
We chose to focus on the factor loadings in the eight-factor model because it had a more distinct factor structure. Based on the results of the EFA and CFA, we have proposed a shortened version of the CBRQ. We wanted to develop a shorter version of the CBRQ so that it would take a shorter amount of time for the patients to fill out, provided that the psychometric properties of the CBRQ would be improved by removing some items.
Model Fit
Initially, we removed all items with the lowest loadings within each factor, had cross-loading in the eight-factor model loadings (Table 3) , and performed an EFA. We were interested in having a questionnaire with as strong indicators as possible, and so we then omitted the (remaining) weakest items in each factor so that we had at least three items in each factor, while ensuring minimal impact on reliability. The items removed were not considered essential according to Chalder, in terms of content validity. The factor structure for the final version of the shortened CBRQ is presented in Table 4 , along with the Cronbach's α value of each subscale. Summary statistics for each subscale and the total score for the shortened CBRQ are presented in Supplementary Digital Content, http://links.lww.com/PSYMED/A423, Table S4 .
EFA showed that a six-factor model fit the data well (relative χ Tables 3 and 4 , it can be seen that the reliability is almost unchanged in the shortened version of the CBRQ, even though there was a reduction in the number of items. It is not surprising that the Cronbach's α values have slightly decreased because it is a function of the number of items. The shortened version of the CBRQ was thought to have good face validity by CFS clinicians. The six-factor model (with 18 items) explained 67% of variance in the data, whereas the eight-factor model (with 40 items) explained 60% of the variance in the data. The short-version CBRQ is presented in Supplementary Digital Content, http://links.lww.com/ PSYMED/A423, Table S5 .
Metric Invariance (MIMIC models)
We ran the MIMIC models using the shortened questionnaire structure presented in Table 4 . Initially, we ran a MIMIC model to see whether there was metric invariance in the items for the data set source (RCT or clinical data set). That is, we used MIMIC models to look at whether the loadings of the items to their corresponding factors differed according to the data set source for people with the same underlying trait score. We then ran MIMIC models within each data set to see whether the items' factor loadings differed for the individuals' age (continuous) or sex (for the same underlying trait score). The items that had metric noninvariance for data set source are summarized in Table S6 , and the items that had metric noninvariance for age and/or sex are summarized in Table S7 in the Supplementary Digital Content, http://links.lww.com/PSYMED/A423.
Based on the MIMIC analyses, there were a number of items in the data set that seemed to have significantly different loadings across data set source. The effect size from the MIMIC models was large for the AL3 and L7 items; moderate for the EA2 and L2 items; and small for SF5 and AL1 (36, 37) . Some items had significant metric noninvariance for sex or age (EA1 and L2 for sex in RCT data set; FA10 and L7 for age in clinical data set; L2 for age in RCT data set). However in most cases (e.g., FA10), the effect size was small (36, 37) . Future research is required to test the replicability of these effects.
Construct Validity
Construct validity can be assessed by comparing the measure of interest to a similar (or different) measure. There are currently no other scales, which specifically measure CFS patients' views/beliefs about their symptoms. Instead, we assessed evidence toward construct validity by examining the correlations between the shortened CBRQ total score and other measures of impairment: the SF36 total score, WSAS, CFQ, HAD total score, HAD anxiety score, and the HAD depression score (Table 5 ). The shortened version of the CBRQ The questions for each of the item abbreviations are written out in full in Table S1 , Supplemental Digital Content, http://links.lww.com/PSYMED/A423. The highest factor loading for each item is boldfaced.
*The Cronbach's α values were obtained using the 3 items that make up each subscale.
had significant correlation with these impairment measures, which were low to moderate in size.
DISCUSSION
Summary of Main Findings
In this article, we investigated the subscale structure of the CBRQ to determine whether the scale originally developed by MossMorris and Chalder (in preparation) and used by studies (16) (17) (18) in CFS populations was reliable and valid or whether a different subscale structure was more appropriate. We also proposed a short version of the CBRQ, which consisted of 18 items and was derived using the results from the EFA and CFA, as well as the expertise of CFS clinicians. EFA was carried out on data from routine clinical practice (n = 576), and then the CFA was conducted using data collected as part of a large RCT (14) (n = 640). Similar results were obtained from both the EFA and CFA where seven-and eight-factor models produced the best fits. The original subscale/factor structure proposed by Moss-Morris and Chalder (in preparation) fit the data well. However, it appeared that the avoidance and resting items should be split into two factors because the resting items had high cross-loading in a seven-factor model. This makes sense because at face value, these items seem to measure different constructs. Large Cronbach's α values (33) were obtained for all the final subscales.
Although the catastrophizing items have been used in previous articles (16, 17) and catastrophizing was found to be one of the mediators of the effects of CBT and Graded Exercise Therapy (GET) for CFS, we found these items to be problematic, with low factor loadings and evidence that they cross-loaded onto other factors. It may be that the items were not specific enough and/or overlapped with other constructs. In the proposed short version of the questionnaire, we have removed these items because we wanted to obtain a questionnaire with as strong indicators as possible. The six-factor model (with 18 items) explained 67% of variance in the data, whereas the eight-factor model (with 40 items) explained 60% of the variance in the data. By removing problematic items, the latent structure became clearer.
We also removed the avoidance items from the short version of the questionnaire because they cross-loaded on the fear avoidance factor or the catastrophizing factor. It is likely that these items are not required in the presence of the fear avoidance items. The subscales/factors in the short version had good reliability and the items had large factor loadings and no cross-loading.
MIMIC models indicated that there may be metric noninvariance in certain items in the short version, i.e., that the loadings of the items on their corresponding factors may differ according to age, sex, or data set source for people with the same underlying latent trait score. The magnitude of the estimates can inform us as to the degree of metric noninvariance present. The effect size estimates for metric noninvariance for data set source were quite large for some of the items (AL3 and L7), which means that the relationship between these items and the trait differs according to the data set. This could be explained by the fact that PACE patients had to meet certain criteria to be included in the clinical trial and these patients had more self-reported disability.
It is important to note that the effect size estimates for the items that had significant metric noninvariance across age and/or sex (Table S7 , Supplemental Digital Content, http://links.lww.com/ PSYMED/A423) are small (36), the largest odds ratio being 1.56. One could use the methods proposed by Hasselblad and Hedges (37) to convert the log odds ratios to a Cohen's d value and come to the same conclusion. This suggests that age and sex differences in the loadings might not be reproduced in smaller samples and should be explored in future research. It may be the case that women respond differently to men in their thinking and coping styles, and older patients may respond differently to younger patients because of experience. Future analyses could adjust for the items that had metric noninvariance for sex and/or age.
We used only baseline data in this study to focus on measurement avoiding the effects of treatment. Although we did not examine the posttreatment measures of the CBRQ in this study, future studies will use longitudinal data analyses of the routine clinic data set to investigate whether the item responses change over time (test-retest reliability). This has been investigated to some extent where mediation analyses were performed using the different subscales of the CBRQ as mediators on the primary outcome (measured by the CFQ and the physical function subscale of the SF36) using the RCT data set (17) and a clinical CFS data set (16) .
Validity
When assessing construct validity, correlations with theoretically similar measures, should be high, whereas correlations with theoretically dissimilar measures should be low. The short-version CBRQ total score had significant and moderate, positive correlations with the WSAS, as well as the HAD total, HAD anxiety, and HAD depression scores, which makes sense because increases in these measures correspond to more disability. The short-version CBRQ had a small and positive correlation with the CFQ, which is not unexpected because CFQ measures fatigue, rather than patient beliefs. The short-version CBRQ total score had a small, negative correlation with the SF36 total score, which makes sense because a lower SF36 score corresponds to more disability. The SF36 measures physical function, rather than beliefs about symptoms, and so it is not unexpected that the SF36 and (short-version) CBRQ have small correlations.
The CBRQ scale has good face validity, and it also has good predictive validity because it changes over time with CBT (16) . The scale items were based on a model of understanding symptom perception in which cognitive and behavioral responses are all important in determining outcomes in terms of symptom severity and disability (9) . Two recent studies that examined the role of cognitive behavioral responses as mediators during the process of CBT support the use of this measure as a predictive tool (16, 17) . The clinic attendees and those who agreed to take part in the RCT may not be representative of the wider population of people with CFS. Those who agreed to take part in the RCT differed to those recruited in the clinic in that the routine clinic attendees had been ill for longer and were more ethnically diverse. Ingman et al. (18) found that black and minority ethnic individuals had more extreme baseline cognitive behavioral responses but that these differences did not affect treatment outcome.
This article was not designed to assess etiology of CFS; its main aim is to assess the reliability and validity of the CBRQ in people with CFS. The CBRQ is designed to assess cognitive behavioral responses in relation to symptoms and one cannot make assumptions about causality. Because fatigue is ubiquitous, these responses could be important in the context of other diseases.
The short version of the CBRQ was developed using psychometric analyses performed on two data sets. This short version has not yet been piloted on patients, and so future analyses should revalidate this proposed short version of the CBRQ with an independent sample of patients that represent the same target population.
In summary, the long and short versions of the CBRQ are reliable and valid scales for measuring cognitive and behavioral responses of patients with CFS. Further research examining the utility of the CBRQ in other conditions would be welcome. 
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